Article

Novartis merges ophthalmics divisions

Duluth, GA-Novartis AG is cutting up to 170 jobs from its ophthalmics business and moving what's left of the operation to New Jersey, where it will join Novartis Pharmaceuticals Corp. (NPC) as a separate business unit.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
Time and motion studies demonstrate workflow efficiencies of Alcon’s Unity VCS in cataract and vitreoretinal surgery
September 16th 2025

Time and motion studies demonstrate workflow efficiencies of Alcon’s Unity VCS in cataract and vitreoretinal surgery

3 Things You Should Know About the GA Pipeline
September 16th 2025

NK Insights: An Interactive Corneal Sensitivity Testing Workshop

Q&A: Sofia Androudi on retinal disorders mimicking inherited retinal diseases
September 16th 2025

Q&A: Sofia Androudi on retinal disorders mimicking inherited retinal diseases

3 Things You Should Know About the GA Pipeline
September 16th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Status of the inner retinal layers in patients with multiple sclerosis
September 16th 2025

Status of the inner retinal layers in patients with multiple sclerosis

Viridian Therapeutics completes enrollment in REVEAL-1 and REVEAL-2 clinical trials for VRDN-003
September 16th 2025

Viridian Therapeutics completes enrollment in REVEAL-1 and REVEAL-2 clinical trials for VRDN-003

© 2025 MJH Life Sciences

All rights reserved.